Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer

被引:9
|
作者
Liang, Bin [1 ]
Shao, Yang [1 ]
Long, Fei [1 ]
Jiang, Shu-Juan [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
EXPRESSION; NETWORK; GEMCITABINE; PROTEINS; DATABASE; PATHWAY; RISK;
D O I
10.1155/2016/3952494
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lung cancer is the primary reason for death due to cancer worldwide, and non-small-cell lung cancer (NSCLC) is the most common subtype of lung cancer. Most patients die from complications of NSCLC due to poor diagnosis. In this paper, we aimed to predict gene biomarkers that may be of use for diagnosis of NSCLC by integrating differential gene expression analysis with functional association network analysis. We first constructed an NSCLC-specific functional association network by combining gene expression correlation with functional association. Then, we applied a network partition algorithm to divide the network into gene modules and identify the most NSCLC-specific gene modules based on their differential expression pattern in between normal and NSCLC samples. Finally, from these modules, we identified genes that exhibited the most impact on the expression of their functionally associated genes in between normal and NSCLC samples and predicted them as NSCLC biomarkers. Literature review of the top predicted gene biomarkers suggested that most of them were already considered critical for development of NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Non-small-cell lung cancer
    Hendriks, Lizza E. L.
    Remon, Jordi
    Faivre-Finn, Corinne
    Garassino, Marina C.
    Heymach, John V.
    Kerr, Keith M.
    Tan, Daniel S. W.
    Veronesi, Giulia
    Reck, Martin
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [23] Non-small-cell lung cancer
    Goldstraw, Peter
    Ball, David
    Jett, James R.
    Le Chevalier, Thierry
    Lim, Eric
    Nicholson, Andrew G.
    Shepherd, Frances A.
    LANCET, 2011, 378 (9804): : 1727 - 1740
  • [24] A review of predictive, prognostic and diagnostic biomarkers for non-small-cell lung cancer: towards personalised and targeted cancer therapy
    Osei, Ernest
    Lumini, Julia
    Gunasekara, Dinindu
    Osei, Beverley
    Asare, Akua
    Laflamme, Raymond
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2020, 19 (04) : 370 - 384
  • [25] Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
    Li, Shumin
    Zhang, Chengyan
    Pang, Guanchao
    Wang, Pingli
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [26] Cetuximab and biomarkers in non-small-cell lung carcinoma
    Patil, Nitin
    Abba, Mohammed
    Allgayer, Heike
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 221 - 231
  • [27] An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer
    Ku, Bo Mi
    Sun, Jong-Mu
    Lee, Se-hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (10) : 933 - 942
  • [28] Targeting angiogenesis in advanced non-small-cell lung cancer: are biomarkers needed?
    G. Metro
    M. Cenci
    A. Baldi
    L. Crinò
    Current Respiratory Care Reports, 2013, 2 (2): : 72 - 78
  • [29] Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
    Liu, Qingyun
    Yu, Zubin
    Yuan, Shuai
    Xie, Weijia
    Li, Chengying
    Hu, Zeyao
    Xiang, Ying
    Wu, Na
    Wu, Long
    Bai, Li
    Li, Yafei
    ONCOTARGET, 2017, 8 (08) : 13048 - 13058
  • [30] Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer
    Passaro, A.
    Palazzo, A.
    Trenta, P.
    Mancini, M. L.
    Morano, F.
    Cortesi, E.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (22) : 3689 - 3700